Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Monday

Biomea Fusion (NASDAQ:BMEA) is expected to be announcing its earnings results before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($1.00) per share for the quarter.

Biomea Fusion Trading Up 3.6 %

Biomea Fusion stock opened at $2.87 on Friday. The firm has a market cap of $104.01 million, a price-to-earnings ratio of -0.72 and a beta of -0.26. Biomea Fusion has a 12 month low of $2.35 and a 12 month high of $16.97. The stock has a fifty day simple moving average of $3.47 and a two-hundred day simple moving average of $6.18.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on BMEA. HC Wainwright reissued a “buy” rating and set a $40.00 price target on shares of Biomea Fusion in a report on Tuesday, January 14th. D. Boral Capital reaffirmed a “buy” rating and set a $16.00 price objective on shares of Biomea Fusion in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Biomea Fusion presently has a consensus rating of “Buy” and an average price target of $29.18.

About Biomea Fusion

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes.